Accendra Health (ACH) Cash from Financing Activities (2009 - 2026)

Accendra Health (ACH) has reported Cash from Financing Activities for 18 consecutive years, with $51.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 44.94% year-over-year to $51.1 million; the TTM figure through Mar 2026 stood at $146.4 million (up 164.16% YoY), while the FY2025 annual figure was $188.1 million, up 170.28% from the prior year.
• Cash from Financing Activities grew to $51.1 million in Q1 2026 per ACH's latest filing, from -$117.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.7 billion in Q1 2022 and bottomed at -$199.6 million in Q3 2024.
• Historically, Cash from Financing Activities has averaged $61.8 million across 5 years, with a median of -$51.2 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 2170.05% — and 2023, when it sank 812.78%.
• Accendra Health's Cash from Financing Activities stood at -$63.5 million in 2022, then advanced by 19.32% to -$51.2 million in 2023, then advanced by 15.85% to -$43.1 million in 2024, then sank by 172.64% to -$117.5 million in 2025, then surged by 143.48% to $51.1 million in 2026.
• Business Quant data shows ACH's Cash from Financing Activities at $51.1 million in Q1 2026, -$117.5 million in Q4 2025, and $181.1 million in Q3 2025.